Back to Search Start Over

BeyondSpring Presents Promising Data for Lead Asset Plinabulin at 2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Source :
Plus Company Updates. January 29, 2018
Publication Year :
2018

Abstract

NEW YORK : BeyondSpring Inc has issued the following press release: BeyondSpring Inc. (NASDAQ:BYSI), a global clinical-stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, announced that [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Plus Company Updates
Publication Type :
News
Accession number :
edsgcl.525409445